NEW YORK, Oct. 4 - Gene Logic of Gaithersburg, Md., said Thursday that Pfizer had extended it subscription to Gene Logic's ToxExpress database module.
Pfizer, which has had access to ToxExpress since 2000, extended its total subscription term to five years.
Gene Logic did not disclose financial terms of the deal.
In January, Gene logic and Pfizer announced an agreement to jointly develop a microarray for toxicology studies using Affymetrix’s GeneChip technology.
Under the agreement, Gene Logic and Pfizer researchers said they would design the array, while Affymetrix would build it. The array will only be available to subscribers of Gene Logic’s ToxExpress and is designed to complement the ToxExpress’s library of toxicity markers.
ToxExpress is a module in the GeneExpress suite of databases. It offers data on the effects of more than 10 toxic compounds on the liver, kidney, bone marrow, and heart of animals.